Fenfen Gu

780 total citations
19 papers, 646 citations indexed

About

Fenfen Gu is a scholar working on Biomaterials, Molecular Biology and Biomedical Engineering. According to data from OpenAlex, Fenfen Gu has authored 19 papers receiving a total of 646 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Biomaterials, 8 papers in Molecular Biology and 7 papers in Biomedical Engineering. Recurrent topics in Fenfen Gu's work include Nanoparticle-Based Drug Delivery (9 papers), RNA Interference and Gene Delivery (7 papers) and Dendrimers and Hyperbranched Polymers (3 papers). Fenfen Gu is often cited by papers focused on Nanoparticle-Based Drug Delivery (9 papers), RNA Interference and Gene Delivery (7 papers) and Dendrimers and Hyperbranched Polymers (3 papers). Fenfen Gu collaborates with scholars based in China. Fenfen Gu's co-authors include Chuling Hu, Shen Gao, Yuan Gao, Qingming Xia, Chunai Gong, Lijuan Zhang, Chong Yao, Zongguang Tai, Zhuo Wang and Yan Li and has published in prestigious journals such as Advanced Functional Materials, Scientific Reports and Journal of Controlled Release.

In The Last Decade

Fenfen Gu

18 papers receiving 643 citations

Peers

Fenfen Gu
Fenfen Gu
Citations per year, relative to Fenfen Gu Fenfen Gu (= 1×) peers Fangfang Wang

Countries citing papers authored by Fenfen Gu

Since Specialization
Citations

This map shows the geographic impact of Fenfen Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fenfen Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fenfen Gu more than expected).

Fields of papers citing papers by Fenfen Gu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fenfen Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fenfen Gu. The network helps show where Fenfen Gu may publish in the future.

Co-authorship network of co-authors of Fenfen Gu

This figure shows the co-authorship network connecting the top 25 collaborators of Fenfen Gu. A scholar is included among the top collaborators of Fenfen Gu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fenfen Gu. Fenfen Gu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Gu, Fenfen, Ping Yang, Lixia Li, & Chao Li. (2024). Drug-induced liver injury associated with savolitinib: a novel case report and causality assessment. BMC Pulmonary Medicine. 24(1). 384–384. 1 indexed citations
2.
Hu, Chuling, Yan Liu, Wei Cao, et al.. (2024). Efficacy and Mechanism of a Biomimetic Nanosystem Carrying Doxorubicin and an IDO Inhibitor for Treatment of Advanced Triple-Negative Breast Cancer. International Journal of Nanomedicine. Volume 19. 507–526. 7 indexed citations
7.
Gu, Fenfen, Chuling Hu, Wei Cao, et al.. (2022). Tumor Microenvironment Multiple Responsive Nanoparticles for Targeted Delivery of Doxorubicin and CpG Against Triple-Negative Breast Cancer. International Journal of Nanomedicine. Volume 17. 4401–4417. 14 indexed citations
8.
Li, Ruonan, et al.. (2021). Synthesis and characterization of PEG coated hollow Fe3O4 magnetic nanoparticles as a drug carrier. Materials Letters. 309. 131357–131357. 16 indexed citations
9.
Hu, Chuling, Fenfen Gu, Chunai Gong, et al.. (2021). Co-delivery of the autophagy inhibitor si-Beclin1 and the doxorubicin nano-delivery system for advanced prostate cancer treatment. Journal of Biomaterials Applications. 36(7). 1317–1331. 13 indexed citations
10.
Li, Xiang, Haotian Zheng, Yan Xue, et al.. (2021). Synthesis and Characterization of Regular Hexagonal Fe3O4 Nanoplates. Russian Journal of Physical Chemistry A. 95(7). 1432–1438. 3 indexed citations
11.
Li, Ruonan, et al.. (2020). Functionalized magnetic nanoparticles for drug delivery in tumor therapy*. Chinese Physics B. 30(1). 17502–17502. 27 indexed citations
12.
Gu, Fenfen, et al.. (2018). Aptamer-conjugated multi-walled carbon nanotubes as a new targeted ultrasound contrast agent for the diagnosis of prostate cancer. Journal of Nanoparticle Research. 20(11). 303–303. 39 indexed citations
13.
Li, Yan, Yuan Gao, Chunai Gong, et al.. (2018). A33 antibody-functionalized exosomes for targeted delivery of doxorubicin against colorectal cancer. Nanomedicine Nanotechnology Biology and Medicine. 14(7). 1973–1985. 188 indexed citations
14.
Xia, Qingming, Chunai Gong, Fenfen Gu, et al.. (2018). Functionalized Multi-Walled Carbon Nanotubes for Targeting Delivery of Immunostimulatory CpG Oligonucleotides Against Prostate Cancer. Journal of Biomedical Nanotechnology. 14(9). 1613–1626. 33 indexed citations
15.
Gong, Chunai, Chuling Hu, Fenfen Gu, et al.. (2017). Co-delivery of autophagy inhibitor ATG7 siRNA and docetaxel for breast cancer treatment. Journal of Controlled Release. 266. 272–286. 86 indexed citations
16.
Chen, Zhongjian, Zongguang Tai, Fenfen Gu, et al.. (2016). Aptamer-mediated delivery of docetaxel to prostate cancer through polymeric nanoparticles for enhancement of antitumor efficacy. European Journal of Pharmaceutics and Biopharmaceutics. 107. 130–141. 67 indexed citations
17.
Yao, Chong, Jiyong Liu, Xin Wu, et al.. (2016). Reducible self-assembling cationic polypeptide-based micelles mediate co-delivery of doxorubicin and microRNA-34a for androgen-independent prostate cancer therapy. Journal of Controlled Release. 232. 203–214. 81 indexed citations
18.
Gu, Fenfen, Chuling Hu, Chong Yao, et al.. (2016). Tumour microenvironment-responsive lipoic acid nanoparticles for targeted delivery of docetaxel to lung cancer. Scientific Reports. 6(1). 36281–36281. 36 indexed citations
19.
Hu, Chuling, Fenfen Gu, Zongguang Tai, et al.. (2016). Synergistic effect of reduced polypeptide micelle for co-delivery of doxorubicin and TRAIL against drug-resistance in breast cancer. Oncotarget. 7(38). 61832–61844. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026